Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride helps protect brain in old male rats.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Finasteride may affect PNMT, causing side effects.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Dutasteride may help shrink prostate cancer tumors.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Store Tectona grandis leaf extracts in slightly acidic, light-protected conditions for best stability.

Women also use 5α-reductase inhibitors, and their effects differ from men.